wsbdaily | Mon, 26 Sep 2022 03:58:39 EST Where you find Tomorrow’s Hot Stocks Yesterday!
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
InMed Pharmaceuticals Inc.(INM)
Summary & Charts
| Price | $ 5.57 | -1.35 (-19.51%) |
| Day's Range | $ 5.12 - 6.81 | |
| Previous Close | $ 6.92 | |
| Market Cap | $ 7.86M USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqCM | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 244.53K | |
| Avg. Volume (20 day) | 2.87M | |
| Rel. Volume (20 day) | 0.09 | |
| Rel. Volume (3 month) | 0.23 | |
| Rating | A+ | Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 45.76 % | Neutral |
| ROE | -0.05 % | Strong Buy |
| ROA | -0.09 % | Strong Buy |
| P/E | -288.53 % | Neutral |
| P/B | 0.39 % | Neutral |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2022 | $ 6.49 | $ 6.81 | $ 5.12 | $ 5.57 | -1.35 | 244,534 | 0.09 | 0.23 | |
| Sep 22, 2022 | $ 7.00 | $ 8.25 | $ 6.72 | $ 6.92 | -0.18 | 414,123 | 0.14 | 0.39 | |
| Sep 21, 2022 | $ 7.26 | $ 7.39 | $ 6.92 | $ 7.10 | -0.35 | 129,205 | 0.04 | 0.12 | |
| Sep 20, 2022 | $ 7.73 | $ 8.88 | $ 7.45 | $ 7.45 | -0.35 | 1,115,458 | 0.37 | 1.06 | |
| Sep 19, 2022 | $ 8.29 | $ 8.29 | $ 7.63 | $ 7.80 | -0.69 | 237,476 | 0.08 | 0.23 | |
| Sep 16, 2022 | $ 9.01 | $ 9.33 | $ 8.32 | $ 8.49 | -1.12 | 213,608 | 0.07 | 0.21 | |
| Sep 15, 2022 | $ 10.77 | $ 10.86 | $ 9.32 | $ 9.61 | -1.39 | 462,101 | 0.16 | 0.46 | |
| Sep 14, 2022 | $ 11.44 | $ 11.50 | $ 9.18 | $ 11.00 | -1.07 | 683,674 | 0.23 | 0.70 | |
| Sep 13, 2022 | $ 15.02 | $ 16.35 | $ 11.45 | $ 12.07 | -6.71 | 2,085,340 | 0.71 | 2.18 | 2 |
| Sep 12, 2022 | $ 15.00 | $ 19.50 | $ 13.78 | $ 18.78 | +7.76 | 31,815,907 | 11.24 | 34.23 | |
| Sep 09, 2022 | $ 10.84 | $ 13.25 | $ 9.09 | $ 11.02 | +2.15 | 2,990,996 | 2.39 | 6.29 | 1 |
| Sep 08, 2022 | $ 9.35 | $ 11.16 | $ 7.79 | $ 8.87 | +0.07 | 659,239 | 0.60 | 1.51 | |
| Sep 07, 2022 | $ 11.40 | $ 12.30 | $ 7.53 | $ 8.80 | +8.45 | 1,027,754 | 0.96 | 2.38 | 1 |
| Sep 06, 2022 | $ 0.38 | $ 0.43 | $ 0.33 | $ 0.35 | +0.03 | 8,083,600 | 7.88 | 19.04 | |
| Sep 02, 2022 | $ 0.32 | $ 0.35 | $ 0.29 | $ 0.32 | +0.01 | 3,855,600 | 6.16 | 12.18 | |
| Sep 01, 2022 | $ 0.23 | $ 0.32 | $ 0.23 | $ 0.31 | +0.07 | 1,497,700 | 3.42 | 5.63 | |
| Aug 31, 2022 | $ 0.26 | $ 0.27 | $ 0.24 | $ 0.24 | -0.02 | 248,300 | 0.68 | 1.00 | |
| Aug 30, 2022 | $ 0.25 | $ 0.27 | $ 0.25 | $ 0.26 | +0.02 | 304,000 | 0.85 | 1.22 | |
| Aug 29, 2022 | $ 0.26 | $ 0.28 | $ 0.24 | $ 0.24 | -0.02 | 426,200 | 1.23 | 1.72 | |
| Aug 26, 2022 | $ 0.27 | $ 0.28 | $ 0.25 | $ 0.26 | +0.01 | 811,100 | 2.47 | 3.32 |
News
The latest news about InMed Pharmaceuticals Inc. (INM).
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | BMO | -- | -- | -- | 0.8M | -- | -- |
| 2022-09-23 | BMO | -- | -- | -- | 0.8M | 1.1K | -99.86% |
| 2022-05-13 | BMO | -6.25 | -6.25 | -- | 310K | 310 | -99.9% |
| 2022-02-14 | BMO | -6 | -7.75 | 29.16% | 120K | -- | -- |
| 2021-11-10 | BMO | -8.75 | -6.25 | 28.58% | -- | -- | -- |
| 2021-09-24 | BMO | -8.5 | -10.25 | 20.58% | -- | -- | -- |
| 2021-05-13 | BMO | -6 | -10.25 | 70.83% | -- | -- | -- |
| 2021-02-11 | BMO | -6 | -9.25 | 54.16% | -- | -- | -- |
Due Diligences
These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.
Brief Overview, * Doing a bit of research into pharmaceutical companies, I found an interesting one. Being InMed Pharmaceuticals, based in Vancouver, Canada, they’re a global leader in development, manufacturing and commercialization of rare cannabinoids. With a subsidiary, Baymedica LLC, they focu... Read More
Brief Overview, * Doing a bit of research into pharmaceutical companies, I found an interesting one. Being InMed Pharmaceuticals, based in Vancouver, Canada, they’re a global leader in development, manufacturing and commercialization of rare cannabinoids. With a subsidiary, Baymedica LLC, they focu... Read More
Top Discussions
These are the top discussions over the last 24-hours that mention the INM stock ticker symbol.
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
@wsbdaily
wsbdaily